Reading the annual reports…
First time this company is opened: we are analysing its official reports. This can take up to a minute; after that the page loads instantly.
First time this company is opened: we are analysing its official reports. This can take up to a minute; after that the page loads instantly.
APT · NYSE · United States · Orthopedic, Prosthetic & Surgical Appliances & Supplies
In shortALPHA PRO TECH LTD is profitable.
Financial health
Solid
Built from five areas over the last five annual reports. Tap an area to see the figures behind it.
| Operating marginShare of each sale left after running the business, before interest and tax. | 6.5% | 38/100 |
|---|---|---|
| Net marginShare of each sale left as profit after every cost, interest and tax. | 6.0% | 44/100 |
| Return on equityProfit earned on the money shareholders put in. Above 15% is strong. | 5.7% | 28/100 |
| Return on invested capitalProfit earned on all the capital used (equity and debt). Above 10% usually means a real competitive edge. | – | n/a |
Weight in the score: 25%
| Current ratioShort-term assets divided by short-term debts. Below 1 can mean tight cash. | 12.94× | 100/100 |
|---|---|---|
| Debt / equityDebt compared with the shareholders' stake. Above 2 is heavily indebted. | – | n/a |
| Net debt / EBITDAYears of operating profit needed to repay net debt. Below 2 is comfortable. | – | n/a |
| Interest coverageHow many times operating profit covers interest. Below 2 is risky. | – | n/a |
| Altman Z''Bankruptcy-risk model. Above 2.6 safe, below 1.1 distress. | 12.40 | 100/100 |
Weight in the score: 25%
| Free cash flow marginCash left from each sale after investments. The money that can pay dividends or reduce debt. | 2.9% | 32/100 |
|---|---|---|
| Free cash flow / net incomeHow much accounting profit turns into real cash. Near 1 or above is healthy. | 0.49× | 24/100 |
| Years with positive free cash flow (last 5) | 4 of 5 | 75/100 |
Weight in the score: 20%
| Profitable years (last 5) | 5 of 5 | 100/100 |
|---|---|---|
| Years of revenue decline (last 5) | 4 of 5 | 0/100 |
| Revenue growth volatility | 14.0% | 59/100 |
| Operating margin volatility | 2.2% | 89/100 |
Weight in the score: 20%
| Revenue growth, 3-year average | -1.6% | 8/100 |
|---|---|---|
| EPS growth, 3-year average | 8.3% | 66/100 |
Weight in the score: 10%
Fiscal year 2025 · change vs prior year
Annual figures as reported. Hover a bar or point for the exact value.
5 older years available with the 10-year history. Essential plan, from €8.25/month →
The last 5 fiscal years from the company's annual reports.
USD millions; negative values in parentheses.
| Fiscal year | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | 69 | 62 | 61 | 58 | 59 |
| Cost of revenue | 43 | 40 | 38 | 35 | 37 |
| Gross profit | 25 | 22 | 23 | 23 | 23 |
| Selling, general & admin | 17 | 16 | 18 | 19 | 18 |
| Operating income | 7.9 | 4.7 | 4.1 | 3.4 | 3.8 |
| Income tax | 1.7 | 1.1 | 1.2 | 1.1 | 1.1 |
| Net income | 6.8 | 3.3 | 4.2 | 3.9 | 3.5 |
| Diluted EPS | $0.50 | $0.26 | $0.35 | $0.35 | $0.33 |
| Diluted shares (millions) | 13 | 13 | 12 | 11 | 11 |
5 older years available with the 10-year history. Essential plan, from €8.25/month →
12.40 Safe zone
Estimates bankruptcy risk from working capital, retained earnings, operating profit and equity. Above 2.6 is considered safe, below 1.1 signals distress.
5/9
Nine yes-or-no tests on profitability, debt, liquidity and efficiency versus the prior year. 7 to 9 is strong, 0 to 3 is weak.
All figures: SEC EDGAR. Ratios and scores are computed by Scorvest (see how it works). Information only, not investment advice. How it works
Latest annual report: Jun 30, 2026 · Data updated Aug 7, 2026